Eisai Co., Ltd announced hat it has launched the in-house discovered and developed antiepileptic drug (AED) Fycompa®, generic name perampanel)...
Read moreAmgen announced the successful closing of the transaction to enter into a strategic collaboration with BeiGene that will significantly accelerate...
Read moreAstraZeneca’s Lokelma has been approved in China for the treatment of adult patients with hyperkalaemia (elevated levels of potassium in...
Read moreThe Syneos Health® Insights Hub, a dynamic destination for what’s next thinking and future-focused insights, released 2020 Health Trends: Changing...
Read moreMerck known as MSD outside the United States and Canada, announced an exclusive worldwide research collaboration and license agreement with...
Read moreCergentis, a genomics company that develops and commercialises kits and services based on its proprietary Targeted Locus Amplification (TLA) technology,...
Read moreFedEx Express is supporting a clinical trial run by Life Science Center in Tokyo, Japan, by shipping pharma products to...
Read moreUS-based Dicerna Pharmaceuticals and Novo Nordisk have signed a deal worth up to around $607m to discover and develop drugs...
Read moreElsevier is working with the National Center for Toxicological Research (NCTR) at the FDA on a predictive drug-induced liver injury...
Read moreAquestive Therapeutics, a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems, announced that Exservan...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.